Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ferromagnetic Nanoparticles Used in New Immunoassays

By HospiMedica staff writers
Posted on 22 Oct 2007
Immunoassays have been developed based on the peroxidase activity of ferric oxide (Fe3O4) magnetic nanoparticles (MNPs).

The nanoparticles are active catalysts, and the catalytic activity is greater in smaller particles. More...
In addition, iron oxide nanoparticles are more stable over a variety of temperatures and varying levels of acidity, giving them an additional advantage over the traditional horseradish peroxidase that is used in the enzyme-linked immunosorbant assay (ELISA).

Most immunoassays are ELISAs. Because it can evaluate the presence of an antigen or antibody in a sample, the ELISA is commonly used to test for human immunodeficiency virus (HIV), hepatitis B, and West Nile Virus. The test basically involves an antigen attached to a solid surface. When the antibody is washed over the surface, it binds to the antigen. The antibody is then linked to an enzyme, usually a peroxidase, which reacts with certain substrates, resulting in a change in color. The evolution of immunoassays has continued with developments such as the fluorimetric immunoassay.

Prof. Xiyun Yan from the National Laboratory of Biomacromolecules in the Institute of Biophysics of the Chinese Academy of Sciences (CAS; Beijing, PR China), and colleagues showed that iron oxide nanoparticles are intrinsically active catalysts for oxidation reactions.

"The magnetic properties allow separation of the target from a complex solution, and the peroxidase assay can then be used to detect and quantify the amount of the target molecule,” said Prof. Yan. According to the CAS scientists, magnetic ELISA assays are already widely used for laboratory and diagnostic purposes. However, the difference when using the intrinsic activity of the MNPs compared to the traditional ELISA, is that there is no need for the binding step with a secondary, enzyme-counjugated antibody.

Prof. Yan and her collaborators have already developed two novel immunoassays (one for hepatitis B and the other for myocardial infarction) that exploit this new discovery. Using the appropriate antibody, the nanoparticles capture the target molecule in solution and then a magnet is used to isolate the nanoparticles. With the simple addition of a peroxidase-sensitive dye, the solution changes from clear to blue in the presence of the nanoparticles.

According to the scientists, the stability, ease of production, and versatility of the iron oxide nanoparticles makes them a powerful tool for a wide range of potential applications in clinical diagnostics, biotechnology, and environmental chemistry.

"The MNP assay would be worth developing commercially, because it is cheaper, faster, more direct, and potentially more sensitive,” said Prof. Yan. "… we are already collaborating with a company to develop the MNP-based immunoassay and to apply MNPs for the treatment of wastewater. The magnetic properties allow separation of the target from a complex solution and the peroxidase assay can then be used to detect and quantify the amount of the target molecule.”

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.